NCT04993469

Brief Summary

For genital gender affirming surgery, it remains unclear to what extent genital sensitivity might be expected and what the impact of this might be on sexual functioning.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
55mo left

Started May 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress53%
May 2021Dec 2030

Study Start

First participant enrolled

May 27, 2021

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

June 4, 2021

Completed
2 months until next milestone

First Posted

Study publicly available on registry

August 6, 2021

Completed
9.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2030

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2030

Last Updated

December 22, 2023

Status Verified

December 1, 2023

Enrollment Period

9.6 years

First QC Date

June 4, 2021

Last Update Submit

December 21, 2023

Conditions

Keywords

PhalloplastyMetoidioplastyVaginoplastyVulvoplasty

Outcome Measures

Primary Outcomes (1)

  • Change in genital sensitivity pattern at 24 months

    Mapping of pressure thresholds of Semmes-Weinstein monofilaments in pre-defined areas of the neo-genital area

    Baseline function test, followed by reassessment at 3, 6, 9, 12, 15, 18, 21 and 24 months of follow-up

Secondary Outcomes (12)

  • Change in postoperative sexual function

    Baseline questionnaire, followed by reassessment at 12 and 24 months of follow-up

  • Change in self-assessment of genital anatomy and genital sensitivity

    Baseline questionnaire, followed by reassessment at 3, 6, 9, 12, 15, 18, 21 and 24 months of follow-up

  • Change in voiding function

    Baseline questionnaire, followed by reassessment at 3, 6, 12 and 24 months of follow-up

  • Change in urinary continence

    Baseline questionnaire, followed by reassessment at 3, 6, 12 and 24 months of follow-up

  • Change in maximum flow rate

    Uroflowmetry at baseline, followed by uroflowmetry at 3, 6, 12 and 24 months of follow-up

  • +7 more secondary outcomes

Study Arms (1)

Genital sensation and sexual functioning assessment

EXPERIMENTAL

Genital sensation testing with clinical assessment and self-examination questionnaire. Sexual functioning testing with questionnaires.

Diagnostic Test: Semmes-Weinstein monofilament testing and questionnaires

Interventions

Semmes-Weinstein test for the assessment of genital sensation Battery of questionnaires assessing sexual function, voiding function, quality of life and patient satisfaction

Genital sensation and sexual functioning assessment

Eligibility Criteria

Age18 Years - 110 Years
Sexall(Gender-based eligibility)
Gender Eligibility DetailsThe study is specific to patients with gender dysphoria who wish to undergo genital gender affirming surgery.
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Voluntarily signed written informed consent according to the rules of Good Clinical Practice (Declaration of Helsinki) and national regulations
  • Patient age ≥ 18 years
  • Transgender male, female of gender non-conforming patient with diagnosed gender dysphoria and the specific wish to undergo genital gender affirming surgery
  • Fit for operation, based on the surgeon's expert opinion
  • Patient is able and willing to attend the follow-up consultations

You may not qualify if:

  • Absence of signed written informed consent and thus a patient unwilling to participate.
  • Patient age \< 18 years
  • Cisgender patients
  • Patients unfit for operation
  • Patient declares that it will be impossible for him to attend the follow-up consultations

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Ghent

Ghent, East-Flanders, 9000, Belgium

RECRUITING

MeSH Terms

Conditions

Gender Dysphoria

Condition Hierarchy (Ancestors)

Sexual Dysfunctions, PsychologicalMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Single group assignment Single centre open label prospective
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 4, 2021

First Posted

August 6, 2021

Study Start

May 27, 2021

Primary Completion (Estimated)

December 31, 2030

Study Completion (Estimated)

December 31, 2030

Last Updated

December 22, 2023

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will not share

Locations